EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

AI approaches for the discovery and validation of drug targets

Aaron Wenteler, Claudia P Cabrera, Wei Wei, Victor Neduva, Michael R Barnes iD

Cambridge Prisms: Precision Medicine · 2024 · 2

DOI: 10.1017/pcm.2024.4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cambridge Prisms: Precision Medicine, online erschienen am 24.05.2024. Verfasst von Aaron Wenteler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Digital Environment Research Institute, Queen Mary University of London, London, United Kingdom. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) holds immense promise for accelerating and improving all aspects of drug discovery, not least target discovery and validation. By integrating a diverse range of biological data modalities, AI enables the accurate prediction of drug target properties, ultimately illuminating biological mechanisms of disease and guiding drug discovery strategies. Despite the indisputable potential of AI in drug target discovery, there are many challenges and obstacles yet to be overcome, including dealing with data biases, model interpretability and generalisability, and the validation of predicted drug targets, to name a few. By exploring recent advancements in AI, this review showcases current applications of AI for drug target discovery and offers perspectives on the future of AI for the discovery and validation of drug targets, paving the way for the generation of novel and safer pharmaceuticals.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencedrug discoverydrug targetsmachine learningmultiomics

Autor:innen und Institutionen

  • Digital Environment Research Institute, Queen Mary University of London, London, United Kingdom.
  • Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • MSD Discovery Centre, London, United Kingdom.
  • NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • The Alan Turing Institute, London, United Kingdom.

ORCID-Profile: Michael R Barnes

Zitieren

APA

Wenteler, A., Cabrera, C. P., Wei, W., Neduva, V., & Barnes, M. R. (2024). AI approaches for the discovery and validation of drug targets. Cambridge Prisms: Precision Medicine, 2. https://doi.org/10.1017/pcm.2024.4

Vancouver

Wenteler A, Cabrera CP, Wei W, Neduva V, Barnes MR. AI approaches for the discovery and validation of drug targets. Cambridge Prisms: Precision Medicine. 2024;2. doi:10.1017/pcm.2024.4

BibTeX
@article{Wenteler2024,
  author = {Wenteler, Aaron and Cabrera, Claudia P and Wei, Wei and Neduva, Victor and Barnes, Michael R},
  title = {AI approaches for the discovery and validation of drug targets},
  journal = {Cambridge Prisms: Precision Medicine},
  year = {2024},
  volume = {2},
  doi = {10.1017/pcm.2024.4}
}
Kostenlos starten →